- 501 Orchard Road, #04-08 Wheelock Place, Singapore 238880
- (65) 6235 4429
- hello@vidaskinclinic.com
- (65) 9830 0597
Most dermal filler treatments are completed without significant complications. However, the injection of fillers is a medical procedure, and no injectable treatment is entirely risk-free. Patients should understand both the expected recovery effects and the symptoms that require prompt assessment.
This article explains how aesthetic concerns such as excess volume, migration, and nodules differ from urgent vascular complications, how each may be managed, and when same-day medical review is appropriate.
Vascular complications are uncommon but urgent. If filler enters or compresses a blood vessel, the tissue supplied by that vessel may be at risk. Published cases describe vascular occlusion managed with prompt hyaluronidase-based treatment, including after low-volume injection. Other reports describe additional treatments used alongside hyaluronidase.
Aesthetic concerns usually allow time for swelling to settle and for a considered plan. Symptoms suggesting a vascular event require immediate contact with a doctor.
Contact the treating clinic urgently rather than waiting for a scheduled review if you develop:
Reference texts and published case reports discuss hyaluronidase as part of filler-complication management, with early recognition and prompt treatment repeatedly emphasised.[1][2][3] If the treating clinic cannot be reached, seek medical attention rather than waiting for symptoms to resolve on their own.
Mild swelling, tenderness, bruising and temporary firmness can occur after filler. Increasing pain, patterned colour change, or visual symptoms fall outside the expected recovery pattern and need urgent assessment.
Several factors may contribute. Superficial placement or injection outside the intended anatomical compartment can make product more visible. Excess volume increases tissue pressure, while highly mobile areas are exposed to repeated muscular movement. Further treatment before the previous product has resolved can also lead to accumulation over time.
Reviews of lip rejuvenation and perioral filler complications use anatomical assessment as the basis for management.[4] Product rheology is also relevant because gels differ in how they resist deformation, spread, and remain cohesive within tissue.[5][6]
Adding more fillers is not usually the first solution for migration. Where the misplaced product is hyaluronic acid, a doctor may recommend reducing it with hyaluronidase, allowing the tissues to settle and then reassessing whether any further treatment is needed.
This process may take several weeks, and follow-up assessments may be needed before the final contour can be evaluated and any further treatment considered.
Small areas of firmness or palpable irregularity during the first days or weeks may relate to swelling, a superficial bolus, or a product that is still integrating. Superficial nodularity has been reported, including in the infraorbital region and with non-hyaluronic-acid products.[7]
A bothersome hyaluronic acid nodule can often be reduced with hyaluronidase following assessment. Options are more limited for permanent or semi-permanent products, which is one reason reversibility is considered carefully in visible, thin-skinned areas.
Nodules that appear weeks or months after treatment require a different assessment. They may be inflammatory and can sometimes follow illness, dental work or vaccination. Infection or biofilm may also need to be considered. Dissolving is not automatically the correct first step.
A delayed lump that is tender, red, warm, fluctuating or worsening should be examined by a doctor rather than self-treated or booked directly for dissolving without assessment.
Patients should understand three important limitations:
Product selection affects both the initial result and the available options if adjustment is needed. Hyaluronic acid is reversible with hyaluronidase, whereas most alternative filler materials are not.
Rheological studies show that filler products differ in resistance to deformation, spread, and cohesivity. These properties influence how a product behaves in tissue and why selection should be matched to the treatment area.
Reversibility is particularly relevant in thin-skinned, highly visible, or mobile areas such as the under-eye and lips. An unwanted HA result can often be reduced, while correction of a non-HA product may be more limited.
A structured approach can help:
A doctor’s registration can be checked through the Ministry of Health’s public register.[9] The Health Sciences Authority regulates medical devices supplied in Singapore according to risk classification, so patients may also ask which product was used and whether it is registered.[10]
Risk reduction begins before injection. It includes assessing whether filler is suitable, understanding the relevant anatomy, selecting a product for the treatment site, using conservative volume, arranging review, and maintaining access to hyaluronidase and an emergency protocol.
The Singapore Medical Council places particular emphasis on informed consent in aesthetic practice, including the discussion of relevant risks.[11] A filler consultation should therefore cover both common recovery effects and uncommon but important complications.
If you are unhappy with a previous filler result or uncertain whether your recovery is normal, an in-person assessment is more reliable than trying to diagnose the concern online. Bring any available records, including the product name, volume, treatment date, and clinic details.
At VIDASKIN, filler review begins by identifying what product is present, where it sits, and what is causing the appearance. The plan may involve waiting, dissolving HA filler, treating a complication, making a conservative correction, or leaving the area untreated.
To learn more or book a consultation, visit or contact us today.
